Obstetrics & Gynecology Doctors in The Dalles, OR Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

James C Faherty, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1810 E 19th St, Suite 209, The Dalles, OR 97058 Phone: 541-296-5657

Brian Christian Macarthur, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1810 E 19th St, Suite 209, The Dalles, OR 97058 Phone: 541-296-5657    Fax: 541-298-5199

Analene Joanne Pentopoulos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1810 E 19th St, Suite 209, The Dalles, OR 97058 Phone: 541-296-5657    Fax: 541-298-5199

Dr. David A Mack, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1810 East 19th St, Suite 209, The Dalles, OR 97058 Phone: 541-296-5657

Miriam D Mcdonell, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1730 E 12th St, The Dalles, OR 97058 Phone: 541-296-9151    Fax: 541-296-9156

News Archive

DNAstack receives NRC-IRAP funding to build cloud-based genomics software platform

DNAstack, a Toronto based company, today is announcing the investment into its cloud-based genomics software platform from the National Research Council of Canada Industrial Research Assistance Program.

Drug therapy may be effective in treating both the manic and depressive phases of bipolar disorder

The condition (bipolar I and II) affects approximately 8 million Americans, who have relied on a combination of drugs to manage their symptoms, and who remain at high risk of committing suicide because of the difficulty in treating the disorder.

Unique program enhances sense of purpose and meaning in life for seniors living independently

A unique program combining a life review writing workshop with conversations between seniors and college students enhances the sense of meaning in life for older adults living independently, finds a new study by NYU's Steinhardt School of Culture, Education, and Human Development.

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

Penn researchers find effective way to inhibit inflammatory response during kidney dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent. Such inflammation can be triggered when the complement cascade, part of the body's innate immune system, is inadvertently activated by modern polymer-based dialysis blood filters.

Read more Medical News

› Verified 1 days ago